Orbimed Advisors Llc Sells 281,408 Shares of Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Stock

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) major shareholder Orbimed Advisors Llc sold 281,408 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $45.02, for a total value of $12,668,988.16. Following the transaction, the insider owned 245,728 shares of the company’s stock, valued at $11,062,674.56. This represents a 53.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Bitwise MARA Option Income Strategy ETF Stock Down 1.9%

NYSEARCA IMRA traded down $0.33 during trading on Wednesday, hitting $17.02. 446 shares of the stock traded hands, compared to its average volume of 5,461. The company has a market capitalization of $3.23 million, a P/E ratio of 340.40 and a beta of 2.88. The firm has a 50-day simple moving average of $16.35 and a 200-day simple moving average of $15.83. Bitwise MARA Option Income Strategy ETF has a 12-month low of $11.99 and a 12-month high of $54.94.

Bitwise MARA Option Income Strategy ETF Company Profile

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.